NEW YORK (GenomeWeb News) – Cancer diagnostics company Cynvenio Biosystems announced today its sequencing laboratory has received CLIA certification.

As a result, the lab, located in Westlake Village, Calif., can accept clinical samples from most of the US. In April the company received licensure to accept clinical samples from California, one of the states that require other regulatory approval in addition to CLIA certification before a lab offering an LDT can accept patient samples from the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.